Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605.
Eur Urol
; 84(6): 536-544, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37596191
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma in Situ
/
Non-Muscle Invasive Bladder Neoplasms
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Eur Urol
Year:
2023
Document type:
Article
Country of publication:
Suiza